Prelude Capital Management’s Cartesian Growth Corp II RENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-244,500
Closed -$2.51M – 1420
2022
Q4
$2.51M Hold
244,500
– – 0.13% 180
2022
Q3
$2.46M Buy
+244,500
New +$2.45M 0.09% 181

Other funds holding RENE

Prelude Capital Management's RENE Position: Q1 2023 in Review

Prelude Capital Management sold out of Cartesian Growth Corp II (RENE) in Q1 2023, closing a stake of 244,500 shares — an estimated $2.51M sold.

Prelude Capital Management first reported a position in RENE in Q3 2022 and held it in 2 quarters. The position peaked at $2.51M in Q4 2022. 50 funds tracked by Wall St. Rank hold RENE as of Q1 2023.

  • Prelude Capital Management reported no remaining Cartesian Growth Corp II position as of Q1 2023 after selling out during the quarter.
  • Prelude Capital Management sold 244,500 Cartesian Growth Corp II shares in Q1 2023, an estimated $2.51M.
  • Prelude Capital Management first reported a position in Cartesian Growth Corp II in Q3 2022 and held it in 2 quarters.
  • Prelude Capital Management's Cartesian Growth Corp II position peaked at $2.51M in Q4 2022.
  • 50 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q1 2023.

Based on Prelude Capital Management's 13F filing for Q1 2023, filed 15 May 2023.